Detailed biophysical characterization of the acid-induced PrP(c) to PrP(β) conversion process.

Prions are believed to spontaneously convert from a native, monomeric highly helical form (called PrP(c)) to a largely β-sheet-rich, multimeric and insoluble aggregate (called PrP(sc)). Because of its large size and insolubility, biophysical characterization of PrP(sc) has been difficult, and there are several contradictory or incomplete models of the PrP(sc) structure. A β-sheet-rich, soluble intermediate, called PrP(β), exhibits many of the same features as PrP(sc) and can be generated using a combination of low pH and/or mild denaturing conditions. Studies of the PrP(c) to PrP(β) conversion process and of PrP(β) folding intermediates may provide insights into the structure of PrP(sc). Using a truncated, recombinant version of Syrian hamster PrP(β) (shPrP(90-232)), we used NMR spectroscopy, in combination with other biophysical techniques (circular dichroism, dynamic light scattering, electron microscopy, fluorescence spectroscopy, mass spectrometry, and proteinase K digestion), to characterize the pH-driven PrP(c) to PrP(β) conversion process in detail. Our results show that below pH 2.8 the protein oligomerizes and conversion to the β-rich structure is initiated. At pH 1.7 and above, the oligomeric protein can recover its native monomeric state through dialysis to pH 5.2. However, when conversion is completed at pH 1.0, the large oligomer "locks down" irreversibly into a stable, β-rich form. At pH values above 3.0, the protein is amenable to NMR investigation. Chemical shift perturbations, NOE, amide line width, and T(2) measurements implicate the putative "amylome motif" region, "NNQNNF" as the region most involved in the initial helix-to-β conversion phase. We also found that acid-induced PrP(β) oligomers could be converted to fibrils without the use of chaotropic denaturants. The latter finding represents one of the first examples wherein physiologically accessible conditions (i.e., only low pH) were used to achieve PrP conversion and fibril formation.

[1]  L. Stryer,et al.  Fluorescence spectroscopy of proteins. , 1968, Science.

[2]  S. Prusiner.  Novel proteinaceous infectious particles cause scrapie. , 1982, Science.

[3]  Stanley B. Prusiner,et al.  Scrapie prion protein contains a phosphatidylinositol glycolipid , 1987, Cell.

[4]  G. J. Raymond,et al.  The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive. , 1991, The Journal of biological chemistry.

[5]  N. A. Rodionova,et al.  Study of the “molten globule” intermediate state in protein folding by a hydrophobic fluorescent probe , 1991, Biopolymers.

[6]  Paul A. Keifer,et al.  Pure absorption gradient enhanced heteronuclear single quantum correlation spectroscopy with improved sensitivity , 1992 .

[7]  F. Richards,et al.  The chemical shift index: a fast and simple method for the assignment of protein secondary structure through NMR spectroscopy. , 1992, Biochemistry.

[8]  A L Burlingame,et al.  Glycosylinositol phospholipid anchors of the scrapie and cellular prion proteins contain sialic acid. , 1992, Biochemistry.

[9]  R J Fletterick,et al.  Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Ad Bax,et al.  Quantitative J correlation: a new approach for measuring homonuclear three-bond J(HNH.alpha.) coupling constants in 15N-enriched proteins , 1993 .

[11]  P. Roller,et al.  Thermal stability and conformational transitions of scrapie amyloid (prion) protein correlate with infectivity , 1993, Protein science : a publication of the Protein Society.

[12]  L. Kay,et al.  Backbone 1H and 15N resonance assignments of the N-terminal SH3 domain of drk in folded and unfolded states using enhanced-sensitivity pulsed field gradient NMR techniques , 1994, Journal of biomolecular NMR.

[13]  P. Roller,et al.  Scrapie amyloid (prion) protein has the conformational characteristics of an aggregated molten globule folding intermediate. , 1994, Biochemistry.

[14]  J. Lowe,et al.  Endosome-lysosomes and neurodegeneration. , 1994, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[15]  R. Marsh,et al.  Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy , 1994, Journal of virology.

[16]  C. Weissmann.  Molecular biology of transmissible spongiform encephalopathies , 1996, Progress in brain research.

[17]  S. Grzesiek,et al.  NMRPipe: A multidimensional spectral processing system based on UNIX pipes , 1995, Journal of biomolecular NMR.

[18]  Eric Oldfield,et al.  1H, 13C and 15N chemical shift referencing in biomolecular NMR , 1995, Journal of biomolecular NMR.

[19]  R. Riek,et al.  NMR structure of the mouse prion protein domain PrP(121–231) , 1996, Nature.

[20]  S. Prusiner.  Transgenetics of prion diseases. , 1996, Current topics in microbiology and immunology.

[21]  S. Prusiner,et al.  Molecular biology and pathogenesis of prion diseases. , 1996, Trends in biochemical sciences.

[22]  W. Surewicz,et al.  pH-dependent Stability and Conformation of the Recombinant Human Prion Protein PrP(90–231)* , 1997, The Journal of Biological Chemistry.

[23]  K Wüthrich,et al.  NMR characterization of the full‐length recombinant murine prion protein, mPrP(23–231) , 1997, FEBS letters.

[24]  S. Hornemann,et al.  A scrapie-like unfolding intermediate of the prion protein domain PrP(121-231) induced by acidic pH. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[25]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[26]  Stanley B. Prusiner,et al.  Nobel Lecture: Prions , 1998 .

[27]  G. J. Raymond,et al.  Strain-dependent Differences in β-Sheet Conformations of Abnormal Prion Protein* , 1998, The Journal of Biological Chemistry.

[28]  J. Kelly,et al.  The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. , 1998, Current opinion in structural biology.

[29]  F. Cohen,et al.  Solution structure of Syrian hamster prion protein rPrP(90-231). , 1999, Biochemistry.

[30]  B. Caughey,et al.  Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease‐resistant state , 1999, The EMBO journal.

[31]  K Wüthrich,et al.  NMR solution structure of the human prion protein. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[32]  B. Chesebro,et al.  Transmissible spongiform encephalopathies and prion protein interconversions. , 2001, Advances in virus research.

[33]  W. Surewicz,et al.  On the Mechanism of α-Helix to β-Sheet Transition in the Recombinant Prion Protein† , 2001 .

[34]  F. Cohen,et al.  Cryptic epitopes in N‐terminally truncated prion protein are exposed in the full‐length molecule: Dependence of conformation on pH , 2001, Proteins.

[35]  J. Collinge.  Prion diseases of humans and animals: their causes and molecular basis. , 2001, Annual review of neuroscience.

[36]  W. Surewicz,et al.  The Role of Disulfide Bridge in the Folding and Stability of the Recombinant Human Prion Protein* , 2001, The Journal of Biological Chemistry.

[37]  F. Cohen,et al.  Pathway Complexity of Prion Protein Assembly into Amyloid* , 2002, The Journal of Biological Chemistry.

[38]  S. Prusiner,et al.  Locally disordered conformer of the hamster prion protein: a crucial intermediate to PrPSc? , 2002, Biochemistry.

[39]  D. Eisenberg,et al.  Seeded conversion of recombinant prion protein to a disulfide-bonded oligomer by a reduction-oxidation process , 2003, Nature Structural Biology.

[40]  S. Prusiner,et al.  Perspectives on prion biology, prion disease pathogenesis, and pharmacologic approaches to treatment. , 2003, Clinics in laboratory medicine.

[41]  Charles D Schwieters,et al.  The Xplor-NIH NMR molecular structure determination package. , 2003, Journal of magnetic resonance.

[42]  F. Cohen,et al.  Prions: so many fibers, so little infectivity. , 2004, Trends in biochemical sciences.

[43]  S. Prusiner,et al.  The peculiar nature of unfolding of the human prion protein , 2004, Protein science : a publication of the Protein Society.

[44]  Fred E. Cohen,et al.  Evidence for assembly of prions with left-handed β-helices into trimers , 2004 .

[45]  N. Sreerama,et al.  On the analysis of membrane protein circular dichroism spectra , 2004, Protein science : a publication of the Protein Society.

[46]  M. Perbandt,et al.  Oligomerization of the proteolytic products is an intrinsic property of prion proteins. , 2004, Biochemical and biophysical research communications.

[47]  Kurt Wüthrich,et al.  Prion protein NMR structures of chickens, turtles, and frogs. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[48]  O. Bocharova,et al.  Synthetic prions generated in vitro are similar to a newly identified subpopulation of PrPSc from sporadic Creutzfeldt‐Jakob Disease , 2005, Protein Science.

[49]  A. Aguzzi,et al.  Approaches to therapy of prion diseases. , 2005, Annual review of medicine.

[50]  David S Wishart,et al.  A simple method to predict protein flexibility using secondary chemical shifts. , 2005, Journal of the American Chemical Society.

[51]  K. Wüthrich,et al.  Prion protein NMR structures of cats, dogs, pigs, and sheep. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[52]  V. Daggett,et al.  Structural properties of prion protein protofibrils and fibrils: an experimental assessment of atomic models. , 2006, Biochemistry.

[53]  E. M. Jones,et al.  The emerging principles of mammalian prion propagation and transmissibility barriers: Insight from studies in vitro. , 2006, Accounts of chemical research.

[54]  W. Surewicz,et al.  β-Sheet core of human prion protein amyloid fibrils as determined by hydrogen/deuterium exchange , 2007, Proceedings of the National Academy of Sciences.

[55]  Nathan J. Cobb,et al.  Molecular architecture of human prion protein amyloid: A parallel, in-register β-structure , 2007, Proceedings of the National Academy of Sciences.

[56]  Heather T. McFarlane,et al.  Atomic structures of amyloid cross-β spines reveal varied steric zippers , 2007, Nature.

[57]  Christopher E. Jones,et al.  NMR characterization of the pH 4 beta-intermediate of the prion protein: the N-terminal half of the protein remains unstructured and retains a high degree of flexibility. , 2007, The Biochemical journal.

[58]  H. Kalbitzer,et al.  Species-specific Differences in the Intermediate States of Human and Syrian Hamster Prion Protein Detected by High Pressure NMR Spectroscopy* , 2007, Journal of Biological Chemistry.

[59]  W. James,et al.  Oligomerization of the Human Prion Protein Proceeds via a Molten Globule Intermediate* , 2007, Journal of Biological Chemistry.

[60]  David S. Wishart,et al.  Application of the random coil index to studying protein flexibility , 2008, Journal of biomolecular NMR.

[61]  Nathan J. Cobb,et al.  Prion Protein Amyloid Formation under Native-like Conditions Involves Refolding of the C-terminal α-Helical Domain* , 2008, Journal of Biological Chemistry.

[62]  P. Hore,et al.  Conformational pH dependence of intermediate states during oligomerization of the human prion protein , 2008, Protein Science.

[63]  B. Caughey,et al.  Distinct Structures of Scrapie Prion Protein (PrPSc)-seeded Versus Spontaneous Recombinant Prion Protein Fibrils Revealed by Hydrogen/Deuterium Exchange* , 2009, The Journal of Biological Chemistry.

[64]  R. Boshuizen,et al.  Heterologous Stacking of Prion Protein Peptides Reveals Structural Details of Fibrils and Facilitates Complete Inhibition of Fibril Growth , 2009, Journal of Biological Chemistry.

[65]  Patrick Walsh,et al.  Core structure of amyloid fibrils formed by residues 106-126 of the human prion protein. , 2009, Structure.

[66]  S. Prusiner,et al.  Prion proteins with pathogenic and protective mutations show similar structure and dynamics. , 2009, Biochemistry.

[67]  H. Schwalbe,et al.  The unfolded state of the murine prion protein and properties of single-point mutants related to human prion diseases. , 2010, Journal of molecular biology.

[68]  K. Wüthrich,et al.  Horse prion protein NMR structure and comparisons with related variants of the mouse prion protein. , 2010, Journal of molecular biology.

[69]  Fei Wang,et al.  Generating a Prion with Bacterially Expressed Recombinant Prion Protein , 2010, Science.

[70]  David Eisenberg,et al.  Identifying the amylome, proteins capable of forming amyloid-like fibrils , 2010, Proceedings of the National Academy of Sciences.